These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17003959)

  • 1. Optimum two-stage designs in case-control association studies using false discovery rate.
    Kuchiba A; Tanaka NY; Ohashi Y
    J Hum Genet; 2006; 51(12):1046-1054. PubMed ID: 17003959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized multi-stage designs controlling the false discovery or the family-wise error rate.
    Zehetmayer S; Bauer P; Posch M
    Stat Med; 2008 Sep; 27(21):4145-60. PubMed ID: 18444249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal DNA pooling-based two-stage designs in case-control association studies.
    Zhao Y; Wang S
    Hum Hered; 2009; 67(1):46-56. PubMed ID: 18931509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False discovery rate control in two-stage designs.
    Zehetmayer S; Posch M
    BMC Bioinformatics; 2012 May; 13():81. PubMed ID: 22559038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Including sampling and phenotyping costs into the optimization of two stage designs for genomewide association studies.
    Müller HH; Pahl R; Schäfer H
    Genet Epidemiol; 2007 Dec; 31(8):844-52. PubMed ID: 17549751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of genetic model parameters for cost-effective designs of genetic association studies using DNA pooling.
    Ji F; Finch SJ; Haynes C; Mendell NR; Gordon D
    BMC Genomics; 2007 Jul; 8():238. PubMed ID: 17634103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient two-stage genome-wide association designs based on false positive report probabilities.
    Kraft P
    Pac Symp Biocomput; 2006; ():523-34. PubMed ID: 17094266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed analysis of the relative power of direct and indirect association studies and the implications for their interpretation.
    Moskvina V; O'Donovan MC
    Hum Hered; 2007; 64(1):63-73. PubMed ID: 17483598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal designs for two-stage genome-wide association studies.
    Skol AD; Scott LJ; Abecasis GR; Boehnke M
    Genet Epidemiol; 2007 Nov; 31(7):776-88. PubMed ID: 17549752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal robust two-stage designs for genome-wide association studies.
    Nguyen TT; Pahl R; Schäfer H
    Ann Hum Genet; 2009 Nov; 73(Pt 6):638-51. PubMed ID: 19839987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of strategies to increase the validity of findings from association studies: size vs. replication.
    Weitkunat R; Kaelin E; Vuillaume G; Kallischnigg G
    BMC Med Res Methodol; 2010 May; 10():47. PubMed ID: 20509879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneously correcting for population stratification and for genotyping error in case-control association studies.
    Cheng KF; Lin WJ
    Am J Hum Genet; 2007 Oct; 81(4):726-43. PubMed ID: 17846998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRESTO: rapid calculation of order statistic distributions and multiple-testing adjusted P-values via permutation for one and two-stage genetic association studies.
    Browning BL
    BMC Bioinformatics; 2008 Jul; 9():309. PubMed ID: 18620604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-stage designs in case-control association analysis.
    Zuo Y; Zou G; Zhao H
    Genetics; 2006 Jul; 173(3):1747-60. PubMed ID: 16624925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal and minimax three-stage designs for phase II oncology clinical trials.
    Chen K; Shan M
    Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal false discovery rate estimation methodology for genome-wide association studies.
    Forner K; Lamarine M; Guedj M; Dauvillier J; Wojcik J
    Hum Hered; 2008; 65(4):183-94. PubMed ID: 18073488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-stage design for multiple testing in large-scale association studies.
    Wen SH; Tzeng JY; Kao JT; Hsiao CK
    J Hum Genet; 2006; 51(6):523-532. PubMed ID: 16691321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements.
    Boessen R; van der Baan F; Groenwold R; Egberts A; Klungel O; Grobbee D; Knol M; Roes K
    Pharm Stat; 2013; 12(6):366-74. PubMed ID: 24214896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between case-control studies and the transmission/disequilibrium test.
    Mitchell LE
    Genet Epidemiol; 2000 Oct; 19(3):193-201. PubMed ID: 11015123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal two-stage genotyping in population-based association studies.
    Satagopan JM; Elston RC
    Genet Epidemiol; 2003 Sep; 25(2):149-57. PubMed ID: 12916023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.